SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-048263
Filing Date
2014-08-11
Accepted
2014-08-11 10:07:28
Documents
11
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v384801_10q.htm 10-Q 317553
2 EXHIBIT 31.1 v384801_ex31-1.htm EX-31.1 8341
3 EXHIBIT 31.2 v384801_ex31-2.htm EX-31.2 8183
4 EXHIBIT 32.1 v384801_ex32-1.htm EX-32.1 4298
5 EXHIBIT 32.2 v384801_ex32-2.htm EX-32.2 4219
  Complete submission text file 0001144204-14-048263.txt   2102582

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rprx-20140630.xml EX-101.INS 214539
7 XBRL TAXONOMY EXTENSION SCHEMA rprx-20140630.xsd EX-101.SCH 24424
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rprx-20140630_cal.xml EX-101.CAL 34346
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rprx-20140630_def.xml EX-101.DEF 126911
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rprx-20140630_lab.xml EX-101.LAB 179346
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rprx-20140630_pre.xml EX-101.PRE 149218
Mailing Address 2408 TIMBERLOCH PLACE B-7 THE WOODLANDS TX 77380
Business Address 2408 TIMBERLOCH PL SUITE B-7 WOODLANDS TX 77380 2817193400
REPROS THERAPEUTICS INC. (Filer) CIK: 0000897075 (see all company filings)

IRS No.: 760233274 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15281 | Film No.: 141029244
SIC: 2836 Biological Products, (No Diagnostic Substances)